Relapsed Follicular Lymphoma in 2026: Evolving Treatment Strategies in the Canadian Context
Follicular lymphoma (FL) is the most common indolent lymphoma, characterized by a relapsing-remitting course over many years and repeated need for systemic therapy.1 Although outcomes for many patients are excellent, with median overall survival (OS) now exceeding 20 years, a subset of patients experiences early relaps...